di Reumatologia, Società Italiana, trans. 2025. “PO:18:276 | Use of Anifrolumab in the Treatment of Difficult-to-Treat Manifestations in Systemic Lupus Erythematosus: Antonella Grimaldi1, Giuseppe Alessandrini2, Laura Quarta1, Maria Rita Ricciardi1, Daniela Costanza1, Clara Minerba1, Eugenio Quarta1 | 1UOC Reumatologia Verona; 2Specialista Dermatologo in Libera Professione, Italy”. Reumatismo 77 (s1). https://doi.org/10.4081/reumatismo.2025.2170.